• Return to Headlines

Downtrend Call Working As Cellular Biomedi Stock Falls 25.7% (CBMG)

By David Diaz

SmarTrend identified a Downtrend for Cellular Biomedi (NASDAQ:CBMG) on March 15th, 2019 at $16.67. In approximately 5 months, Cellular Biomedi has returned 25.71% as of today's recent price of $12.38.

Cellular Biomedi share prices have moved between a 52-week high of $25.00 and a 52-week low of $11.63 and are now trading 8% above that low price at $12.51 per share. Over the past week, the 200-day moving average (MA) has gone down 0.2% while the 50-day MA has declined 1.4%.

Cellular Biomedicine Group, Inc., a clinical stage biopharmaceutical company, develops therapies for cancer and degenerative diseases in Greater China. It focuses on developing and marketing cell-based therapies to treat various diseases, such as cancer, orthopedic, and metabolic diseases.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Cellular Biomedi.

Log in and add Cellular Biomedi (CBMG) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights cellular biomedi

Ticker(s): CBMG